Reactome | BMS-214662 [cytosol]

Schema > ChemicalDrug > Entries

compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9656755] Rothfels, Karen, 2019-08-02
crossReference	[DatabaseIdentifier:12020745] Mondo:0004992 [DatabaseIdentifier:9717729] ChEBI:167655
dbId	9656754
disease	[Disease:1500689] cancer
displayName	BMS-214662 [cytosol]
inDisease	true
literatureReference	[LiteratureReference:9656488] Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity
maxDepth	1
memberOf	[DefinedSet:R-ALL-9653479] FNTB inhibitors [cytosol]
modified	[InstanceEdit:9717734] Stephan, Ralf, 2021-03-15
name	BMS-214662
referenceEntity	[ReferenceTherapeutic:iuphar.ligand:8026] BMS-214662 [Guide to Pharmacology:8026]
schemaClass	ChemicalDrug
stId	R-ALL-9656754

(hasMember)

Cite Us!